Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aerosol therapy for asthma.

R Dhand1

  • 1Division of Pulmonary and Critical Care Medicine, Stritch School of Medicine, Loyola University of Chicago, IL, USA.

Current Opinion in Pulmonary Medicine
|December 23, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microbiome-scale analysis of aerosol facemask contamination during nebulization therapy in hospital.

The Journal of hospital infection·2023
Same author

Microbiome-based source identification of microbial contamination in nebulizers used by inpatients.

The Journal of hospital infection·2022
Same author

What the pulmonary specialist should know about the new inhalation therapies.

The European respiratory journal·2011
Same author

Consensus statement: aerosols and delivery devices.

Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine·2009
Same author

Advanced nebulizer designs employing vibrating mesh/aperture plate technologies for aerosol generation.

Current drug delivery·2008
Same author

Comparative analysis of methods to measure aerosols generated by a vibrating mesh nebulizer.

Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine·2007
Same journal

Nonsteroid treatment options in (pulmonary) sarcoidosis. When to consider and why?

Current opinion in pulmonary medicine·2026
Same journal

Multidisciplinary approach in cardiac sarcoidosis: to biopsy or not?

Current opinion in pulmonary medicine·2026
Same journal

Low diffusion capacity in pulmonary hypertension.

Current opinion in pulmonary medicine·2026
Same journal

Toward precision imaging in interstitial lung disease: advances in quantitative imaging and artificial intelligence.

Current opinion in pulmonary medicine·2026
Same journal

Oxygen therapy in interstitial lung disease - navigating benefit and burden.

Current opinion in pulmonary medicine·2026
Same journal

Preclinical and clinical advances in pulmonary hypertension associated with systemic sclerosis.

Current opinion in pulmonary medicine·2026
See all related articles

Proper use of inhaled asthma medications requires the right delivery device. New aerosol devices aim to improve drug delivery to the lungs, reduce side effects, and meet patient needs.

Area of Science:

  • Pulmonary medicine
  • Pharmacology
  • Biomedical engineering

Background:

  • Inhaled medications are crucial for asthma management.
  • Effective drug delivery depends on appropriate device use.
  • Chlorofluorocarbon (CFC) metered-dose inhalers are currently prevalent.

Purpose of the Study:

  • To highlight the importance of the drug-device "couple" for optimal asthma treatment.
  • To outline criteria for ideal aerosol delivery devices.
  • To introduce the potential of new-generation devices.

Main Methods:

  • Review of current aerosol delivery technologies.
  • Analysis of requirements for effective inhaled therapy.
  • Discussion of emerging aerosol technologies.

Related Experiment Videos

Main Results:

  • Optimal therapeutic outcomes require a synergistic drug-device relationship.
  • Key device characteristics include efficient lung deposition, cost-effectiveness, ease of use, and minimal side effects.
  • New aerosol devices show promise in meeting these criteria.

Conclusions:

  • The selection of an appropriate aerosol delivery device is as critical as the inhaled drug itself.
  • Future aerosol devices are expected to enhance therapeutic efficacy and patient compliance in asthma management.